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Background Nonablative fractionated laser resurfacing improves the texture of trea-
ted skin, but little is known about the molecular mechanisms that underlie clini-
cal improvements.
Objectives We sought to examine and quantify the time course and magnitude of
dermal matrix changes that occur in response to nonablative fractionated laser
resurfacing, with the dual goals of better understanding the molecular mecha-
nisms that underlie clinical improvements and of gaining knowledge that will
enable evidence-based treatment parameter optimization.
Methods Twenty patients (mean age 58 years) with photodamaged skin were
focally treated on dorsal forearms with a nonablative fractionated laser. Serial skin
samples were obtained at baseline and at various times after treatment. Biopsies
were examined with real-time polymerase chain reaction technology and immu-
nohistochemical techniques.
Results Laser treatment resulted in an initial inflammatory response as indicated by
statistically significant induction of proinflammatory cytokines (interleukin-1b
and tumour necrosis factor-a). This was followed by substantial increases in lev-
els of several matrix metalloproteinases and later by significant induction of type
I collagen. Dermal remodelling was noted with both low and high microbeam
energy treatment parameters.
Conclusions Nonablative fractionated laser resurfacing induces a well-organized
wound-healing response that leads to substantial dermal remodelling and colla-
gen induction. Surprisingly, only minimal differences were observed between
lower and higher microbeam energy settings. These data suggest that lower
microbeam energy ⁄higher microbeam density treatment parameters, which are
generally better tolerated by patients, may yield dermal changes similar to those
that result from higher microbeam energy ⁄ lower microbeam density treatment
parameters.
Ablative laser resurfacing techniques provide marked clinical
improvements in the signs of photoageing, but such procedures
require substantial healing time and are fraught with the po-
tential for significant complications.1–3 Alternatively, traditional
nonablative laser treatments have proven to be clinically useful
for minimizing dyspigmentation and hypervascularity in photo-
damaged skin, but results with respect to textural improve-
ments in rhytides and scars have generally been modest.4–6
To give potential enhancement of the efficacy of nonablative
laser photorejuvenation, the concept of fractionated photo-
thermolysis was introduced.7 With fractionated photothermol-
ysis, infrared laser irradiation is applied to the skin, generating
microscopic columns of heated tissue with water acting as the
primary energy-absorbing molecule. Epidermal integrity gen-
erally remains intact and untreated skin found between the
laser-irradiated columns facilitates rapid healing, thus allowing
for minimal social down time. Fractionated photothermolysis
has revolutionized laser therapy for photodamaged skin and a
variety of other conditions including striae and scars.8–12
When nonablative lasers are applied in a fractionated format,
clinically significant textural improvements in the skin are
achievable with minimal risk. Several authors have examined
the clinical effects of fractionated laser therapy and have dem-
onstrated substantial efficacy.
In comparison, few studies have objectively examined the
cellular and molecular effects of nonablative fractionated
photothermolysis. Prior work that has included histological
evaluation of treated skin has revealed rapid re-epithelializa-
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tion associated with an inflammatory infiltrate and eventual
reorganization of the dermal matrix.11,13 There is also a pilot
study that examines the histological effects of altering treat-
ment settings of nonablative fractionated lasers in a pig
model.14 However, a detailed direct quantitative analysis of
the cutaneous molecular and cellular alterations that result in
humans from such treatment is lacking.
We hypothesize that induction of a cutaneous wound-heal-
ing response to the laser therapy underlies the clinical
improvements in skin texture that have been reported by
several authors. We thus sought to examine and quantify
processes involved in dermal matrix remodelling that occur
in response to nonablative fractionated laser resurfacing, with
the dual goals of better understanding the mechanisms that
underlie clinical improvements and of gaining knowledge that
will enable evidence-based treatment parameter optimization.
Materials and methods
Volunteer recruitment and inclusion ⁄exclusion criteria
This study was approved by the institutional review board of
the University of Michigan Medical School, and written
informed consent was obtained from all study subjects prior to
entry into the study. Human volunteers included in the study
were those of either gender of any racial ⁄ethnic group who
were at least 18 years of age with clinically evident photodam-
age of the forearm skin globally rated by investigators as at least
moderate in severity. Included subjects were deemed to be in
generally good health and willing and able to comprehend and
comply with the requirements of the study protocol. Potential
subjects were excluded for having used oral retinoids within
1 year of study entry, active infection or a history of herpetic
infection of the forearm skin, a history of abnormal scarring, a
history of allergy or sensitivity to lidocaine or topical anaesthet-
ics, and a medical history or concurrent illness that investigators
felt precluded safe participation in this study. Pregnant or
breastfeeding women were also excluded. A minimum 2-week
wash-out period was required for all subjects using topical
agents on their forearm skin. In total, 20 subjects (two women
and 18 men) were enrolled in the comparative study (15 vs.
70 mJ). Subjects’ age ranged from 51 to 73 (mean 58) years.
Fractionated photothermolysis treatment and skin
biopsies
For each patient, the specific site to be treated was marked by
an investigator. Measurements from anatomical landmarks
such as moles, scars or dyspigmented areas were documented
to ensure that subsequent biopsies were obtained from laser-
treated areas. Locally injected 1% lidocaine was used to
achieve anaesthesia prior to laser treatment and biopsy. Frac-
tionated photothermolysis treatment was performed on a
localized area of photodamaged forearm skin using a 1550-
nm erbium doped fibre laser (Fraxel SR 1500 Laser ⁄Fraxel
re:store; Reliant Technologies, Mountain View, CA, U.S.A.)
utilizing the following treatment parameters: treatment level
8, eight passes, and energy of 7, 15, 30 or 70 mJ. Total
energy (in kJ) applied to the skin with each set of treatment
parameters was recorded. For laser energy comparison studies,
both energy levels (15 and 70 mJ) were delivered to distinct
sites on the same forearm. Treatment was well tolerated and
there were no treatment-related adverse events in any subjects.
Treated skin became immediately oedematous and erythema-
tous, but these expected changes resolved within several days
of treatment. Prior to laser treatment, a baseline punch biopsy
(4 mm in diameter) from untreated forearm skin was
obtained under sterile conditions from each subject. Additional
full-thickness skin samples were obtained 1, 7, 14, 21 and
28 days after laser treatment. Biopsy sites were spaced a mini-
mum of 2 cm apart. Immediately after biopsy, skin samples
were embedded in Optimal Cutting Temperature embedding
medium (Tissue-Tek OCT; Miles, Naperville, IL, U.S.A.), fro-
zen in liquid nitrogen, and stored at )80 C until processing.
Sirius red collagen staining
Frozen skin sections (7 lm thick) were fixed in 2% parafor-
maldehyde for 20 min at 4 C, and stained for 1 h in Picro-
Sirius solution, as described by Sweat et al.15 (0Æ1% solution of
Direct Red 80 in saturated aqueous picric acid, both from
Sigma Chemical Co., St Louis, MO, U.S.A.). Skin sections were
then washed in 0Æ01 mol L)1 HCl for 2 min, dehydrated, and
mounted with organic mounting medium (Dako, Carpinteria,
CA, U.S.A.). Digital images were taken of stained sections that
were visualized by microscopy with bright light (where colla-
gen appears dark pink ⁄red), and with polarized light (where
thick, mature collagen fibres fluoresce in red, and thin colla-
gen fibres fluoresce in green).
RNA extraction, reverse transcription, and quantitative
real-time polymerase chain reaction
RNA extraction from whole skin biopsy samples, reverse tran-
scription, and quantification by quantitative real-time polymer-
ase chain reaction was performed as previously described.16
Custom primers and probes were used for collagen I
(COL1A1), collagen III (COL3A1), matrix metalloproteinase
(MMP)-1, MMP-3, MMP-9 and 36B4 (primer sequences avail-
able upon request). All other primer-probe sets were validated
gene expression assays (TaqMan; Applied Biosystems, Foster
City, CA, U.S.A.) (assay references available upon request).
Results are presented as fold change in treated vs. untreated
skin sample, normalized to transcript levels of housekeeping
gene 36B4 (RPLP0, ribosomal protein, large, P0).
Immunohistochemistry
Frozen skin sections (7 lm thick) were immunostained using
antibodies directed to laminin c2 (kalicrin; AbCam, Cam-
bridge, MA, U.S.A.), heat shock protein 70 kDa (HSP70;
Biogenex, San Ramon, CA, U.S.A.), neutrophil elastase (Dako),
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MMP-1, MMP-3, MMP-9 or procollagen I (all from Chem-
icon ⁄Millipore, Billerica, MA, U.S.A.). Tissue-bound primary
antibody was visualized with a secondary antibody–peroxi-
dase–AEC system (Biogenex) as previously described.16
Estimation of laser beam number and depth of dermal
penetration
Frozen skin sections were obtained 24 h after laser treatment
and were immunostained for procollagen I as described above.
Areas where laser treatment caused denaturation of collagen
were clearly demarcated by a lack of staining. Unstained areas
(‘columns’) were quantified using the image analysis software
component of a laser capture microscope (Leica AS LMD;
Leica, Allendale, NJ, U.S.A.). Three parameters were measured
for each section: column number, column width, and column
dermal depth (in lm, from location of basement membrane
to deepest dermal point). Measurements were made in dupli-
cate on consecutive sections for each skin sample.
Procollagen I protein measurement
Procollagen I protein levels were quantified in skin samples by
enzyme-linked immunosorbent assay (ELISA) using a commer-
cial kit (Panvera, Madison, WI, U.S.A.), and normalized to
sample dermal volume, as previously described.17
Statistical analysis
Fold induction of biomarkers over time was compared with
baseline levels with paired sample t-tests. Differences were
considered statistically significant when P < 0Æ05, using a
two-tailed test. When necessary, logarithmic transformations
of the data were made before analysis to achieve normality.
Data were analysed with SPSS statistical software (SPSS,
Chicago, IL, U.S.A.). Data are presented as mean ± SEM.
Results
Skin damage induced by fractional photothermolysis
Histologically, focal areas of intercellular oedema (‘microvesi-
cles’) were observed in the epidermis 24 h after laser treatment
(Fig. 1a, b). Column-like areas of altered dermal collagen fibrils
were observed in the papillary dermis 24 h after laser treat-
ment. These areas were evidenced both by Sirius red staining,
which specifically stains collagen fibrils (Fig. 1c, d; damaged
collagen demarcated by thin dotted lines), and procollagen I
immunostaining, which reveals cell-associated and extracellular
matrix-associated procollagen I protein (Fig. 1e, f).
Fractional photothermolysis induces focal heat shock
response, but does not destroy the basement membrane
In the epidermis, fractional photothermolysis induced a rapid
and transient expression of HSP70 protein, a heat shock
protein that protects against misfolding of proteins during
heat stress18 (Fig. 2a–g). In addition, laminin c2 immuno-
staining indicated that the basement membrane remained es-
sentially intact 1 day following the procedure, and revealed
partial detachment of basal keratinocytes from the basement
membrane beneath the ‘microvesicles’ (Fig. 2h, i).
Characterization of damaged dermal areas induced by
fractional photothermolysis
Based on the laser’s software design, increasing energy levels
decreases the density of individual microbeams for a given
selected ‘treatment level’. This reciprocal relationship causes
the ‘percentage surface area coverage’ displayed on the
device’s touch screen to remain constant. Subjects were treated
with the laser on photoaged forearms with energy settings of
7, 15, 30 or 70 mJ. Skin samples obtained 24 h after treat-
ment were immunostained for procollagen I and used to mea-
sure column number and dimensions as described in Materials
and methods. Representative staining for each treatment set-
ting and mean measurements are presented in Figure 3. As
expected, the dermal depth of laser microbeam penetration
was increased with increasing energy, averaging 134 ± 24,
207 ± 16, 253 ± 18 and 413 ± 32 lm after 7, 15, 30 and
70 mJ, respectively (n = 4 for 7 and 30 mJ, n = 13 for 15
and 70 mJ; Fig. 3f). A similar dose-dependent increase in
mean dermal column width with increased energy settings
was observed in the same samples (ranging from
87Æ4 ± 5Æ3 lm at 15 mJ to 213 ± 14 lm at 70 mJ, n = 13,
P < 0Æ001; Fig. 3g). However, the number of columns per
section was decreased with increased microbeam energy
(mean of 6Æ5, 5Æ7, 2Æ8 and 2Æ8 columns ⁄section for 7, 15, 30
and 70 mJ, respectively (n = 4 for 7 and 30 mJ, n = 13 for
15 and 70 mJ; Fig. 3h). The total volume of thermal damage
at varying settings was mathematically estimated to be similar
at all energy settings, given that microbeam density decreases
with increasing microbeam energy. Based on these results, we
selected 15 and 70 mJ microbeam energy settings as represen-
tative of lower and higher energy settings, respectively, for
subsequent comparative purposes.
Fractional photothermolysis induces a rapid
inflammatory reaction in photodamaged human skin
in vivo
Fractionated photothermolysis quickly triggered an acute
inflammatory response, as evidenced by neutrophil infiltration
(Fig. 4a–c) and acute elevation of the two key proinflam-
matory cytokines tumour necrosis factor (TNF)-a (Fig. 4d)
and interleukin (IL)-1b (Fig. 4e), 1 day after treatment. Inter-
estingly, the neutrophil infiltrate appeared denser in samples
treated with the 70 mJ vs. the 15 mJ energy setting (Fig. 4c
vs. b). Consistent with an acute inflammatory response, TNF-a
transcript levels were found to be elevated in laser-treated skin
as compared with baseline levels 24 h post-treatment (115-
and 45-fold for 70 and 15 mJ, respectively, n = 10,
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Fig 1. Epidermal and dermal damage induced by fractional photothermolysis treatment of photodamaged human skin. Photodamaged forearm skin
was untreated (a, c, e) or treated with fractional photothermolysis at 70 mJ energy setting (b, d, f), as described in Materials and methods. Skin
damage was assessed 24 h post-treatment. (a, b) Sirius red staining, viewed with nonpolarized light, reveals focal areas of intercellular oedema
(‘microvesicles’) in the epidermis (whitish appearance) of treated skin. (c, d) Sirius red staining, viewed with polarized light, reveals areas of
altered collagen fibrils in the papillary dermis (demarcated by dotted lines). Heavy dashed line indicates dermoepidermal junction. (e, f)
Procollagen I immunostaining reveals areas of reduced staining in the papillary dermis of treated skin. Images are representative of 10 subjects.
Original magnification · 60.
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P < 0Æ05). The difference between the two treatment energy
settings was statistically significant (P < 0Æ01). Levels of TNF-
a rapidly declined over the next 2 weeks after treatment
(Fig. 4d). IL-1b mRNA levels were also found to be elevated
1 day post-treatment in the majority of treated individuals
(Fig. 4e) (seven of 10 for 15 mJ treatment setting, ranging
from 1Æ6- to 13Æ0-fold greater than baseline levels, and eight
of 10 individuals for 70 mJ treatment setting, ranging from
2Æ0- to 18Æ9-fold greater than baseline levels; P < 0Æ05).
Fractional photothermolysis increases matrix
metalloproteinase expression in photodamaged human
skin in vivo
Proinflammatory cytokines are known to induce several MMPs,
and previous work has demonstrated the key role played by
these MMPs in remodelling of dermal proteins following a
variety of light-based treatments.17 We thus measured MMP-1,
MMP-3 and MMP-9 mRNA levels following fractionated
photothermolysis treatment with 15 and 70 mJ settings. As
shown in Figure 5a, MMP-1 mRNA levels were significantly
increased over baseline 1 day after nonablative fractionated
laser treatment (153- and 276-fold using 15 and 70 mJ
energy treatment parameters, respectively, n = 10, P < 0Æ01).
The difference in magnitude of induction was significant
between the two treatment levels (P < 0Æ01). Levels of MMP-
1 mRNA returned to baseline 1 week following laser expos-
ure. Similar results were obtained for MMP-3 mRNA levels,
which were acutely and significantly elevated 69-fold (n = 10,
P < 0Æ01) and 90-fold (n = 10, P < 0Æ01) 1 day after 15 and
70 mJ treatments, respectively (Fig. 5b). However, the differ-
ence in MMP-3 induction between the two laser settings
1 day after treatment was not statistically significant
(P = 0Æ249). As observed with MMP-1, levels of MMP-3
quickly returned to baseline levels within 1 week. These





Fig 2. Fractional photothermolysis induces focal heat shock response, but does not destroy the basement membrane in photodamaged human skin
in vivo. Photodamaged forearm skin was treated with fractional photothermolysis with 15 or 70 mJ energy settings, and analysed for heat shock
markers. (a–g) Heat shock protein 70 immunostaining indicates rapid and transient thermal response in epidermal keratinocytes located above
epidermal microvesicles. (a) Untreated skin; (b–d) 15 mJ; (e–g) 70 mJ; (b, e) day 1; (c, f) day 7; (d, g) day 14. (h, i) Laminin c2
immunostaining indicates that the basement membrane remains intact. (h) Untreated skin; (i) 70 mJ at day 1. Note the partial detachment of
basal keratinocytes from the basement membrane beneath the ‘microvesicles’ (white arrow). Laminin c2 staining is red, counterstaining is blue.
Images are representative of 10 subjects. Original magnification · 120.
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indicated that MMP-3 protein was produced primarily around
thermally damaged zones 1 day post-treatment, but was not
detectable 1 week after treatment (Fig. 5c–i). Similarly, MMP-
9 transcript levels were found to be elevated 24 h after treat-
ment, with both energy settings (P < 0Æ01; Fig. 5j). The
increase in MMP-9 mRNA levels was relatively persistent after
70 mJ energy treatment and remained 36 ± 14-fold increased
at 2 weeks after treatment (n = 10, P < 0Æ01). Increased
MMP-9 mRNA persisted for at least 4 weeks after treatment in
nine of 10 individuals tested (17Æ2 ± 4Æ4 the baseline levels,
n = 10, P < 0Æ01; Fig. 5j). However, MMP-9 mRNA levels
quickly tapered back to baseline levels within 1 week after the
15 mJ energy treatment (Fig. 5j). These results were con-
firmed at the protein level: MMP-9 protein was detected by
immunohistochemistry in the dermis and epidermis surround-
ing the damaged skin at 24 h after treatment (Fig. 5k–q).
MMP-9 protein expression was rapidly reduced following
15 mJ energy treatment, but persisted in the dermis of skin
areas treated with the 70 mJ energy setting for at least
2 weeks after treatment (Fig. 5q).
Fractional photothermolysis increases collagen I and III
gene expression in photodamaged human skin in vivo
Consistent with the known sequence of events that takes place
during the cutaneous wound-healing reaction,19 we measured
an acute initial decline in collagen I mRNA levels 24 h after
treatment (0Æ36 ± 0Æ07 and 0Æ41 ± 0Æ08-fold vs. baseline lev-
els with 15 and 70 mJ, respectively, n = 10, P < 0Æ01;









Fig 3. Characterization of damaged dermal areas induced by fractional photothermolysis treatment. Photodamaged forearm skin was treated with
fractional photothermolysis with increasing laser microbeam energy (7, 15, 30 or 70 mJ energy settings), and dermal reduction of collagen I
immunostaining was quantified 24 h after treatment. Procollagen I immunostaining in (a) untreated skin, and after fractional photothermolysis
with (b) 7 mJ, (c) 15 mJ, (d) 30 mJ and (e) 70 mJ energy settings. Black arrowheads indicate bottom of photothermolysis column.
Computerized image analysis of procollagen I immunostaining was performed to quantify (f) mean ± SEM depth of damaged dermal areas; (g)
mean ± SEM width of damaged dermal areas, and (h) mean ± SEM number of columns per section. n = 4 for 7 and 30 mJ, n = 10 for 15 and
70 mJ. *P < 0Æ05 vs. 15 mJ.
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waned, new collagen production was observed in treated skin,
after both the 15 and 70 mJ energy setting treatments: colla-
gen I mRNA levels rose steadily over the subsequent 2 weeks,
peaking at week 2 with 3Æ1- and 5Æ0-fold vs. baseline levels
(n = 20, P < 0Æ01) with 15 and 70 mJ energy settings,
respectively (Fig. 6a). These levels were maintained at least
until week 4 post-treatment, both with the 15 mJ setting
(2Æ9 ± 0Æ6 and 3Æ1 ± 0Æ6-fold vs. baseline at week 3 and 4,
respectively, n = 10, P < 0Æ01) and the 70 mJ setting
(4Æ0 ± 0Æ8 and 5Æ0 ± 1Æ4-fold vs. baseline at week 3 and 4,
respectively, n = 10, P < 0Æ01). Interestingly, despite a trend
towards relatively greater collagen I mRNA induction with the
70 mJ setting, the difference between collagen I mRNA induc-
tion in response to 15 or 70 mJ energy settings was not statis-
tically different at 2 or 3 weeks after treatment (P = 0Æ086,
P = 0Æ072, respectively). However, the amount of induction
in response to 70 mJ energy treatment was greater than in
response to 15 mJ energy treatment at 4 weeks post-treatment
(n = 10, P < 0Æ05).
Similar to collagen I, we observed a transient decrease in
collagen III mRNA levels 1 day post-treatment (0Æ29 ± 0Æ05
and 0Æ33 ± 0Æ06-fold vs. baseline levels with 15 and 70 mJ,
respectively, n = 10, P < 0Æ01; Fig. 6b). Collagen III mRNA
levels were maximal 2 weeks after treatment with 2Æ6- and
3Æ9-fold vs. baseline levels (n = 20, P < 0Æ01) with 15 and
70 mJ energy settings, respectively (Fig. 6b). Substantial
induction of collagen III mRNA was noted to persist until at
least 28 days after laser exposure with both 15 mJ (2Æ4 ± 0Æ6
and 3Æ0 ± 0Æ6-fold vs. baseline at weeks 3 and 4, respectively,
n = 10, P < 0Æ01) and 70 mJ (4Æ0 ± 0Æ7 and 3Æ5 ± 0Æ5-fold
vs. baseline at weeks 3 and 4, respectively, n = 10, P < 0Æ01)
laser energy treatment parameters. Collagen III mRNA induc-
tion at weeks 2 and 3 was statistically different between the
two energy treatment settings (P < 0Æ05 and P < 0Æ01, respec-
tively), but was not statistically different at week 4 (n = 10
per group, P = 0Æ152).
Fractional photothermolysis increases procollagen I
protein expression in photodamaged human skin in vivo
Immunohistochemistry indicated that increased procollagen I
production occurred throughout the dermis (Fig. 7a–i), albeit
greater in the papillary dermis compared with the deep reticu-
lar dermis (Fig. 7d–i). Quantification of procollagen I protein
by specific ELISA (Fig. 7j) was consistent with observed induc-
tion of collagen I mRNA levels. After a transient decrease in
procollagen I protein levels 1 day post-treatment (0Æ57 ± 0Æ09
and 0Æ51 ± 0Æ05-fold vs. baseline levels with 15 and 70 mJ,
respectively, n = 10, P < 0Æ01), procollagen I protein levels
were induced at 2 weeks after treatment (4Æ0- and 2Æ9-fold vs.
baseline levels with 15 and 70 mJ energy settings, respec-
tively; n = 20, P < 0Æ01; Fig. 7j). Procollagen I protein induc-
tion was maximal at weeks 3 and 4, reaching 6Æ4 ± 2Æ4 and
6Æ3 ± 2Æ1-fold vs. baseline at week 4, with 15 and 70 mJ
energy settings, respectively; n = 10, P < 0Æ01). Procollagen I
protein induction was not statistically different between treat-
ment with 15 and 70 mJ energy settings (P = 0Æ391, 0Æ939
and 0Æ489, for weeks 2, 3 and 4, respectively).
Discussion
In the present study, we evaluated the effects of nonablative




Fig 4. Fractional photothermolysis treatment induces a rapid
inflammatory reaction in photodamaged human skin. Photodamaged
forearm skin was treated with fractional photothermolysis with 15 or
70 mJ energy settings and analysed for markers of inflammation.
Neutrophil elastase immunostaining 24 h after treatment in (a)
untreated skin, or skin treated with (b) 15 mJ or (c) 70 mJ energy
setting reveals intense neutrophil infiltrate in the dermis and
epidermal vesicles of treated skin. Original magnification · 60.
(d) mRNA levels of tumour necrosis factor (TNF)-a and
(e) interleukin (IL)-1b were quantified by real-time reverse
transcription–polymerase chain reaction. n = 10; *P < 0Æ05 vs. no
treatment (No Tx); P < 0Æ01 vs. 15 mJ. Results are shown as
mean ± SEM.
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Fig 5. Fractional photothermolysis treatment increases matrix metalloproteinase (MMP) expression in photodamaged human skin in vivo.
Photodamaged forearm skin was treated with fractional photothermolysis with 15 or 70 mJ energy settings and analysed for MMP expression.
Normalized mRNA levels for (a) MMP-1, (b) MMP-3 and (j) MMP-9 were quantified by real-time reverse transcription–polymerase chain
reaction. n = 20 for no treatment (No Tx) and day 14, n = 10 for day 1 and 7; *P < 0Æ01 vs. day 0; P < 0Æ01 vs. 15 mJ. Results are shown as
mean ± SEM. Immunohistochemical localization of protein expression for (c–i) MMP-3 and (k–q) MMP-9. (c, k) Untreated skin; (d–f, l–n)
15 mJ; (g–i, o–q) 70 mJ; (d, g, l, o) day 1; (e, h, m, p) day 7; (f, i, n, q) day 14. Images are representative of 10 individuals. Original
magnification · 60.
 2010 The Authors
BJD  2010 British Association of Dermatologists 2010 163, pp757–768
764 Mechanisms of fractionated laser resurfacing, J.S. Orringer et al.
photoaged human skin in vivo. We first demonstrated the pres-
ence of thermally altered skin columns in the epidermis and
dermis of treated skin, visible 24 h after treatment. The
depths, widths and densities of columns were dependent upon
laser energy settings. In a recently reported in vitro study,
Thongsima et al.20 also reported on the patterns of histological
damage seen after nonablative fractionated photothermolysis.
While slightly deeper and wider areas of thermal alteration
were reported in that study, differences from the data pre-
sented here are likely to be based on methodological nuances
such as measuring the widest breadth of damage vs. our mea-
surements of the average width of damage. The focus of that
study was on a comparison of two different laser systems, but
in general, the principle of being able to manipulate the pat-
tern of thermal damage with changes in laser treatment
parameters held true between that study and the current work.
In addition, we demonstrated that a single fractional photo-
thermolysis treatment induces a wound-healing reaction char-
acterized by early and acute induction of an inflammatory
reaction, followed by matrix remodelling as evidenced by new
procollagen production. The wound-healing process detailed
here offers substantial evidence as to the efficacy of nonabla-
tive fractionated photothermolysis and begins the process of
revealing the molecular mechanisms that are involved. Nota-
bly, the cutaneous response to nonablative fractionated photo-
thermolysis appears to mirror that produced by more invasive
treatments with traditional ablative resurfacing.21
In examining a variety of therapeutic interventions often
used to improve the appearance of photodamaged skin such
as tretinoin applications, microdermabrasion, filler injections,
photodynamic therapy, and both ablative and nonablative
laser therapy, our group and others have developed a para-
digm by which the efficacy of a treatment may be predicted
by quantitative molecular measurements.17,21–29 In keeping
with the findings of a growing body of clinically oriented lit-
erature that suggests fractionated photothermolysis to be an
effective means by which to improve the skin’s appearance,
our molecular data suggest substantial dermal remodelling
that compares favourably with that seen with a variety of
other treatments, despite the nonablative nature of this ap-
proach. Indeed, we have demonstrated reproducible and sig-
nificant dermal remodelling including marked induction of
procollagen I in treated skin. More than any other factor
examined to date, collagen induction appears to correlate with
eventual clinical efficacy.
Beyond determining that a given procedure is effective in
improving skin texture, the process of developing rational,
evidence-based treatment parameters is a daunting task facing
cosmetic dermatologists. With respect to nonablative fraction-
ated laser therapy, we have attempted to begin the process of
optimizing laser settings. Here, it is noteworthy that both
shallow and more deeply penetrating fractionated infrared
laser treatments were capable of producing substantial collagen
induction. In fact, at the time points examined, low micro-
beam energy treatments generally induced rather similar
molecular changes to those that resulted from high microbeam
energy treatments. These data suggest that lower microbeam
energy ⁄higher microbeam density treatments may even be
preferable given the relatively lower level of pain experienced
by patients at these settings. However, it is important to note
that the current data alone are insufficient to necessarily rec-
ommend a change in treatment strategies. Evaluations of
molecular changes at later time points in more subjects and at
varying treatment parameters are required, more definitely to
define optimal laser settings.
The laser used in our study automatically adjusts microbeam
density when energy per microbeam level is changed.20 Thus,
it was not possible to make a strict comparison of the effects
of microbeam energy settings, while maintaining a constant
number of microbeams per area. Therefore, we compared the
effects of lower microbeam energy ⁄higher microbeam density
with the effects of higher microbeam energy ⁄ lower micro-
beam density treatments. The observed similarity of skin
responses to low and high energy settings may reflect the fact
that, under each set of conditions, the measured total energy
applied to the skin and estimated total volume of skin photo-
thermolysis were very similar. Thus, it is possible that the total
energy (in kJ) applied to the skin and the extent of thermal
damage may be more predictive of clinical efficacy than the
energy settings for individual microbeams with this device.
Clearly, large well-designed clinical trials of patients treated at
(a)
(b)
Fig 6. Fractional photothermolysis treatment increases collagen I and
III gene expression in photodamaged human skin. Normalized mRNA
levels of (a) COL1A1 and (b) COL3A1 were quantified by real-time
reverse transcription–polymerase chain reaction after fractional
photothermolysis with 15 mJ or 70 mJ energy settings. n = 20 for no
treatment (Tx) and day 14, n = 10 for day 1 and 7; *P < 0Æ01 vs. day
0; P < 0Æ05 vs. 15 mJ. Results are shown as mean ± SEM.
 2010 The Authors
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varying settings will be required to clarify the issue of optimal
treatment parameters.
Our study examined molecular changes after a single non-
ablative fractionated photothermolysis treatment, whereas treat-
ment is sometimes performed on a serial basis in the clinical
setting. The cumulative molecular effects of multiple treatments
on dermal remodelling are speculative at this point. It should
also be noted that the final time point observed in our study
was 4 weeks following treatment, a time at which collagen
induction had yet to return to baseline levels. It thus remains
possible that greater differences in dermal remodelling might
be observed between the high and low energy settings at later
time points, although the similarities in the observed kinetics
argue against that possibility. In addition, due to the practical
limitations of obtaining multiple skin samples from the face,
treatments were applied to sun-damaged forearm skin.
Although one of the advantages of nonablative fractionated
photothermolysis is the fact that it may be used at a variety of
anatomical locations off the face, the most common uses for
this laser therapy involve treatment of facial skin. However, we
have used photodamaged forearm skin as a model to study
cutaneous molecular alterations in a variety of previous studies
and have found that the skin’s fundamental wound-healing







Fig 7. Fractional photothermolysis treatment increases procollagen I protein expression in photodamaged human skin in vivo. Photodamaged
forearm skin was treated with fractional photothermolysis using 15 or 70 mJ energy settings and analysed for procollagen I protein synthesis by
immunohistochemistry and enzyme-linked immunosorbent assay (ELISA). Immunostaining for procollagen I at 28 days post-treatment indicates
increased procollagen I protein expression throughout the dermis. (a, d, g) Untreated skin; (b, e, h) 15 mJ; (c, f, i) 70 mJ. (a–c) Original
magnification · 60; (d–f) upper dermis, original magnification · 240; (g–i) lower dermis, original magnification · 240. (j) Procollagen I protein
quantification by ELISA in skin extracts. n = 20 for no treatment (Tx) and day 14, n = 10 for day 1, 7, 21 and 28; *P < 0Æ01 vs. no treatment.
Differences between 15 and 70 mJ were not statistically significant at any time points. Results are shown as mean ± SEM.
 2010 The Authors
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believe that the current study is a valid predictor of cutaneous
responses to the treatment in general, including on the face.
Clinical applications for fractionated photothermolysis con-
tinue to increase and such laser therapy seems destined to play
a central role in the treatment of wrinkles, scars and other
unwanted cutaneous textural changes in the coming years. An
evolving understanding of the molecular mechanisms related
to these treatments will be vital for ultimate optimization of
treatment protocols. As therapeutic options to improve the
skin’s appearance continue to expand, a combination of clini-
cal and translational research will be vital in ensuring that
these new treatments are being utilized to the maximal advan-
tage of our patients.
What’s already known about this topic?
• Nonablative fractionated lasers are clinically effective
and offer brief down time and minimal risk. Scars,
wrinkles and other textural issues may be improved
with such laser treatments.
• Columns of thermally altered skin are seen microscopi-
cally.
• Histology of treated skin shows inflammation and reor-
ganization of the dermal matrix.
What does this study add?
• A detailed quantitative analysis of the cutaneous molec-
ular and cellular alterations that result from nonablative
fractionated laser resurfacing.
• A better understanding the mechanisms involved in
such treatment.
• A rationale for evidence-based treatment parameter opti-
mization.
Acknowledgments
We thank Suzan Rehbine, LPN for her help in coordinating
this study, Heather Kovarik, LPN for her assistance during
patient treatments, Stephanie Cooke, BS, Yuan Shao, PhD, and
Savina Aneja, BA, for their technical help. We also acknowl-
edge the assistance of Laura Van Goor, BFA for her assistance
with the preparation of the figures. This study was supported
by the University of Michigan Department of Dermatology
Laser Research Fund.
References
1 Alster T, Lupton J. Prevention and treatment of side effects and
complications of cutaneous laser resurfacing. Plast Reconstr Surg 2002;
109:308–16.
2 Nanni C, Alster T. Complications of carbon dioxide laser resurfac-
ing – an evaluation of 500 patients. Dermatol Surg 1998; 24:315–20.
3 Ratner D, Tse Y, Marchell N et al. Cutaneous laser resurfacing. J Am
Acad Dermatol 1999; 41:365–89.
4 Goldberg D, Samady J. Intense pulsed light and Nd:YAG laser
non-ablative treatment of facial rhytids. Lasers Surg Med 2001;
28:141–4.
5 Zelickson B, Kilmer S, Bernstein E. Pulsed dye laser therapy for sun
damaged skin. Lasers Surg Med 1999; 25:229–36.
6 Tanzi E, Alster T. Comparison of a 1450-nm diode laser and a
1320-nm Nd:YAG laser in the treatment of atrophic facial scars: a
prospective clinical and histologic study. Dermatol Surg 2004;
30:152–7.
7 Manstein D, Herron GS, Sink RK et al. Fractional photothermolysis:
a new concept for cutaneous remodeling using microscopic pat-
terns of thermal injury. Lasers Surg Med 2004; 34:426–38.
8 Alster TS, Tanzi EL, Lazarus M. The use of fractional laser photo-
thermolysis for the treatment of atrophic scars. Dermatol Surg 2007;
33:295–9.
9 Bak H, Kim BJ, Lee WJ et al. Treatment of striae distensae with
fractional photothermolysis. Dermatol Surg 2009; 35:1215–20.
10 Katz TM, Goldberg LH, Friedman PM. Nonablative fractional
photothermolysis for the treatment of striae rubra. Dermatol Surg
2009; 35:1430–3.
11 Vasily DB, Cerino ME, Ziselman EM et al. Non-ablative fractional
resurfacing of surgical and post-traumatic scars. J Drugs Dermatol
2009; 8:998–1005.
12 Wanner M, Tanzi EL, Alster TS. Fractional photothermolysis: treat-
ment of facial and nonfacial cutaneous photodamage with a 1,550-
nm erbium-doped fiber laser. Dermatol Surg 2007; 33:23–8.
13 Laubach HJ, Tannous Z, Anderson RR et al. Skin responses to frac-
tional photothermolysis. Lasers Surg Med 2006; 38:142–9.
14 Walgrave S, Zelickson B, Childs J et al. Pilot investigation of the
correlation between histological and clinical effects of infrared frac-
tional resurfacing lasers. Dermatol Surg 2008; 34:1443–53.
15 Sweat F, Puchtler H, Rosenthal SI. Sirius red F3ba as a stain for
connective tissue. Arch Pathol 1964; 78:69–72.
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